CaRi-Heart screens being reviewed by technician
- Landmark collaboration with Caristo Diagnostics positions NCH at the forefront of preventive cardiology
- NCH cardiologists to present collaboration plans at American Heart Association 2025 Scientific Sessions on Nov. 8
November 5, 2025 — Naples Comprehensive Health (NCH) and Caristo Diagnostics announced that NCH Rooney Heart Institute has become the first hospital in the nation to use both CaRi-Plaque™ and CaRi-Heart®, two AI-powered imaging-based technologies that identify signs of heart disease and predict a patient’s risk of heart attack up to 10 years before symptoms appear.
This collaboration marks a significant step forward in the use of artificial intelligence to prevent cardiovascular disease, shifting the focus from reacting to heart attacks to stopping them before they happen.
Caristo’s FDA-cleared CaRi-Plaque™ technology analyzes coronary CT angiography (CCTA) scans, the first-line test for patients with chest pain, to identify high-risk plaque that may lead to future heart attacks. CaRi-Heart™ is the only technology in the world able to detect and quantify coronary inflammation, an early driver of heart disease, without waiting for patients to develop visible plaque…